Genenta Science Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.53	4.58	3.69	29.79	37.24
Short-Term Investments	22.62	8.08	15.08	-	-
Cash & Short-Term Investments	28.15	12.66	18.78	29.79	37.24
Cash Growth	122.35%	-32.57%	-36.98%	-19.99%	140.80%
Other Current Assets	1.83	1.81	2.48	1.93	1.52
Total Current Assets	29.98	14.47	21.26	31.72	38.76
Net Property, Plant & Equipment	0.02	0.04	0.08	0.11	0.02
Other Long-Term Assets	1.89	0.31	1.01	1.6	1.24
Total Assets	31.89	14.82	22.35	33.44	40.03
Accounts Payable	1.81	0.5	0.47	1.19	0.19
Accrued Expenses	0.19	1.26	1.01	0.69	0.84
Other Current Liabilities	0.12	0.34	0.26	0.3	0.1
Total Current Liabilities	2.12	2.1	1.74	2.18	1.14
Long-Term Debt	7.6	-	-	-	-
Other Long-Term Liabilities	0.33	0.23	0.18	0.12	0.03
Total Long-Term Liabilities	7.93	0.23	0.18	0.12	0.03
Total Liabilities	10.05	2.33	1.91	2.3	1.17
Common Stock	84.26	68.46	67.34	66.6	65.88
Accumulated Other Comprehensive Income	0.17	0.09	0.23	-	-
Retained Earnings	-62.59	-56.06	-47.14	-35.47	-27.02
Shareholders' Equity	21.84	12.5	20.43	31.14	38.86
Total Liabilities & Equity	31.89	14.82	22.35	33.44	40.03
Total Debt	7.6	0	0	0	0
Net Cash (Debt)	20.55	12.66	18.78	29.79	37.24
Net Cash Growth	62.30%	-32.57%	-36.98%	-19.99%	140.80%
Net Cash Per Share	1.04	0.69	1.03	1.64	2.47
Book Value	21.84	12.5	20.43	31.14	38.86
Book Value Per Share	1.11	0.68	1.12	1.71	2.58
Tangible Book Value	21.84	12.5	20.43	31.14	38.86
Tangible Book Value Per Share	1.11	0.68	1.12	1.71	2.58

SEC Filings: 10-K · 10-Q